These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 29932556)

  • 1. [Circadian Regulation and Its Disorders in Parkinson's Disease Patients. Part 2. Experimental Models, Alpha-Synuclein and Melatonin.].
    Ukraintseva YV; Kovalzon VM
    Fiziol Cheloveka; 2016 Sep; 42(5):108-120. PubMed ID: 29932556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian dysfunction in a mouse model of Parkinson's disease.
    Kudo T; Loh DH; Truong D; Wu Y; Colwell CS
    Exp Neurol; 2011 Nov; 232(1):66-75. PubMed ID: 21864527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease as a neuroendocrine disorder of circadian function: dopamine-melatonin imbalance and the visual system in the genesis and progression of the degenerative process.
    Willis GL
    Rev Neurosci; 2008; 19(4-5):245-316. PubMed ID: 19145986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [PROTECTIVE ROLE OF MELATONIN IN ETIOLOGY AND COURSE OF PARKINSON'S DISEASE: EXPERIMENTAL EVIDENCE.].
    Arushanyan EB; Naumov SS
    Eksp Klin Farmakol; 2016; 79(9):38-44. PubMed ID: 29787671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daily rhythms of serotonin metabolism and the expression of clock genes in suprachiasmatic nucleus of rotenone-induced Parkinson's disease male Wistar rat model and effect of melatonin administration.
    Mattam U; Jagota A
    Biogerontology; 2015 Feb; 16(1):109-23. PubMed ID: 25430725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-synuclein, epigenetics, mitochondria, metabolism, calcium traffic, & circadian dysfunction in Parkinson's disease. An integrated strategy for management.
    Phillipson OT
    Ageing Res Rev; 2017 Nov; 40():149-167. PubMed ID: 28986235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired Photic Entrainment of Spontaneous Locomotor Activity in Mice Overexpressing Human Mutant α-Synuclein.
    Pfeffer M; Zimmermann Z; Gispert S; Auburger G; Korf HW; von Gall C
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29865270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian rhythms, Neuroinflammation and Oxidative Stress in the Story of Parkinson's Disease.
    Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
    Cells; 2020 Jan; 9(2):. PubMed ID: 32012898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of circadian melatonin secretion pattern at different stages of Parkinson's disease.
    Bordet R; Devos D; Brique S; Touitou Y; Guieu JD; Libersa C; Destée A
    Clin Neuropharmacol; 2003; 26(2):65-72. PubMed ID: 12671525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin and the circadian system: contributions to successful female reproduction.
    Reiter RJ; Tamura H; Tan DX; Xu XY
    Fertil Steril; 2014 Aug; 102(2):321-8. PubMed ID: 24996495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.
    Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A
    Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal changes underlie MPEP-mediated suppression of the acquisition and expression of pramipexole-induced place preference in an alpha-synuclein rat model of Parkinson's disease.
    Loiodice S; McGhan P; Gryshkova V; Fleurance R; Dardou D; Hafidi A; Nogueira da Costa A; Durif F
    J Psychopharmacol; 2017 Oct; 31(10):1323-1333. PubMed ID: 28631520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of dopamine disrupts circadian rhythms in a mouse model of Parkinson's disease.
    Fifel K; Cooper HM
    Neurobiol Dis; 2014 Nov; 71():359-69. PubMed ID: 25171792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin-dopamine interactions: from basic neurochemistry to a clinical setting.
    Zisapel N
    Cell Mol Neurobiol; 2001 Dec; 21(6):605-16. PubMed ID: 12043836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of the circadian system in Parkinson's disease patients.
    Fifel K
    Mov Disord; 2017 May; 32(5):682-692. PubMed ID: 27859638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic rhythms and Parkinson's disease: a chronopharmacologic approach to considering fluctuations in function.
    Bruguerolle B; Simon N
    Clin Neuropharmacol; 2002; 25(4):194-201. PubMed ID: 12151906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily chronomics of proteomic profile in aging and rotenone-induced Parkinson's disease model in male Wistar rat and its modulation by melatonin.
    Jagota A; Mattam U
    Biogerontology; 2017 Aug; 18(4):615-630. PubMed ID: 28577110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motor deficits and beta oscillations are dissociable in an alpha-synuclein model of Parkinson's disease.
    Brys I; Nunes J; Fuentes R
    Eur J Neurosci; 2017 Aug; 46(3):1906-1917. PubMed ID: 28370471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.